发布求助
文献互助 智能选刊 最新文献

Oncology Times最新文献

筛选
英文 中文
Antitumor Activity With Belzutifan in Advanced Clear Cell RCC 贝珠替凡对晚期透明细胞 RCC 的抗肿瘤活性
Oncology Times Pub Date : 2024-03-01 DOI: 10.1097/01.cot.0001009908.72202.ed
Dibash Kumar Das
{"title":"Antitumor Activity With Belzutifan in Advanced Clear Cell RCC","authors":"Dibash Kumar Das","doi":"10.1097/01.cot.0001009908.72202.ed","DOIUrl":"https://doi.org/10.1097/01.cot.0001009908.72202.ed","url":null,"abstract":"","PeriodicalId":510505,"journal":{"name":"Oncology Times","volume":"7 7","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140083367","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Belantamab Combination Offers PFS Benefit in R/R Multiple Myeloma 贝仑单抗复方制剂为急性/慢性多发性骨髓瘤患者带来疗效
Oncology Times Pub Date : 2024-03-01 DOI: 10.1097/01.cot.0001009948.60927.e0
M. Fuerst
{"title":"Belantamab Combination Offers PFS Benefit in R/R Multiple Myeloma","authors":"M. Fuerst","doi":"10.1097/01.cot.0001009948.60927.e0","DOIUrl":"https://doi.org/10.1097/01.cot.0001009948.60927.e0","url":null,"abstract":"","PeriodicalId":510505,"journal":{"name":"Oncology Times","volume":"60 16","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140085565","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Impact of Breast Cancer-Related Health Disparities in Black Women 与乳腺癌相关的健康差异对黑人妇女的影响
Oncology Times Pub Date : 2024-03-01 DOI: 10.1097/01.cot.0001009912.17568.36
F. Wiley
{"title":"The Impact of Breast Cancer-Related Health Disparities in Black Women","authors":"F. Wiley","doi":"10.1097/01.cot.0001009912.17568.36","DOIUrl":"https://doi.org/10.1097/01.cot.0001009912.17568.36","url":null,"abstract":"","PeriodicalId":510505,"journal":{"name":"Oncology Times","volume":" 13","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140091388","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Impact of NGS Mutation Signature on MMR Testing for Immunotherapy NGS 基因突变特征对麻风腮免疫疗法检测的影响
Oncology Times Pub Date : 2024-03-01 DOI: 10.1097/01.cot.0001009872.61780.4a
Dibash Kumar Das
{"title":"The Impact of NGS Mutation Signature on MMR Testing for Immunotherapy","authors":"Dibash Kumar Das","doi":"10.1097/01.cot.0001009872.61780.4a","DOIUrl":"https://doi.org/10.1097/01.cot.0001009872.61780.4a","url":null,"abstract":"","PeriodicalId":510505,"journal":{"name":"Oncology Times","volume":" 14","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140091642","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
CAR-T Cells to Control Multiple Myeloma Growth 控制多发性骨髓瘤生长的 CAR-T 细胞
Oncology Times Pub Date : 2024-03-01 DOI: 10.1097/01.cot.0001009944.34160.61
Dibash Kumar Das
{"title":"CAR-T Cells to Control Multiple Myeloma Growth","authors":"Dibash Kumar Das","doi":"10.1097/01.cot.0001009944.34160.61","DOIUrl":"https://doi.org/10.1097/01.cot.0001009944.34160.61","url":null,"abstract":"","PeriodicalId":510505,"journal":{"name":"Oncology Times","volume":"29 6","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140084223","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mental Health Issues Among AML Patients on Venetoclax 服用 Venetoclax 的急性髓细胞白血病患者的心理健康问题
Oncology Times Pub Date : 2024-03-01 DOI: 10.1097/01.cot.0001009924.21900.ae
M. Fuerst
{"title":"Mental Health Issues Among AML Patients on Venetoclax","authors":"M. Fuerst","doi":"10.1097/01.cot.0001009924.21900.ae","DOIUrl":"https://doi.org/10.1097/01.cot.0001009924.21900.ae","url":null,"abstract":"","PeriodicalId":510505,"journal":{"name":"Oncology Times","volume":"70 2","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140085160","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
How to Harmonize Variability in AI Biomarker Assessment Tools 如何协调人工智能生物标志物评估工具的差异性
Oncology Times Pub Date : 2024-03-01 DOI: 10.1097/01.cot.0001009840.08322.11
P. Eastman
{"title":"How to Harmonize Variability in AI Biomarker Assessment Tools","authors":"P. Eastman","doi":"10.1097/01.cot.0001009840.08322.11","DOIUrl":"https://doi.org/10.1097/01.cot.0001009840.08322.11","url":null,"abstract":"","PeriodicalId":510505,"journal":{"name":"Oncology Times","volume":"17 6","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140084005","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Exploring Early Detection Saliva Epigenetics for Esophageal Cancer 探索食道癌的早期检测唾液表观遗传学
Oncology Times Pub Date : 2024-03-01 DOI: 10.1097/01.cot.0001009916.27689.45
Dibash Kumar Das
{"title":"Exploring Early Detection Saliva Epigenetics for Esophageal Cancer","authors":"Dibash Kumar Das","doi":"10.1097/01.cot.0001009916.27689.45","DOIUrl":"https://doi.org/10.1097/01.cot.0001009916.27689.45","url":null,"abstract":"","PeriodicalId":510505,"journal":{"name":"Oncology Times","volume":"65 10","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140085341","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Olutasidenib as a Breakthrough for R/R mIDH1 AML Patients Olutasidenib 是治疗 R/R mIDH1 AML 患者的突破性药物
Oncology Times Pub Date : 2024-03-01 DOI: 10.1097/01.cot.0001009932.86369.ce
Dibash Kumar Das
{"title":"Olutasidenib as a Breakthrough for R/R mIDH1 AML Patients","authors":"Dibash Kumar Das","doi":"10.1097/01.cot.0001009932.86369.ce","DOIUrl":"https://doi.org/10.1097/01.cot.0001009932.86369.ce","url":null,"abstract":"","PeriodicalId":510505,"journal":{"name":"Oncology Times","volume":"114 6","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140089590","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Tactics of Multiple Myeloma in Evading Targeted Immunotherapies 多发性骨髓瘤逃避靶向免疫疗法的策略
Oncology Times Pub Date : 2024-03-01 DOI: 10.1097/01.cot.0001009844.75140.19
Dibash Kumar Das
{"title":"Tactics of Multiple Myeloma in Evading Targeted Immunotherapies","authors":"Dibash Kumar Das","doi":"10.1097/01.cot.0001009844.75140.19","DOIUrl":"https://doi.org/10.1097/01.cot.0001009844.75140.19","url":null,"abstract":"","PeriodicalId":510505,"journal":{"name":"Oncology Times","volume":"58 23","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140085713","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
首页 上一页 下一页 尾页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：481959085
Book学术官方微信